Medicinal Chemistry Perspectives in the Design of Novel Antiviral Agents
International Journal of Drug Delivery Technology · 04.06.2026 · 16 (46s)
DOI: 10.25258/ijddt.16.46s.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.06.2026. Verfasst von Vustelamuri Padmavathi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The continuous emergence and re-emergence of viral pathogens pose a significant global health challenge, necessitating the development of effective and innovative antiviral therapies. Despite substantial progress in antiviral drug discovery, current treatments are often limited by issues such as drug resistance, narrow-spectrum activity, and suboptimal pharmacokinetic profiles. Medicinal chemistry plays a pivotal role in addressing these challenges by enabling the rational design and optimization of antiviral agents with improved efficacy, selectivity, and safety. This review provides a comprehensive overview of medicinal chemistry perspectives in the design of novel antiviral agents, focusing on key druggable targets, including viral enzymes, entry mechanisms, and host factors. It further discusses major design strategies such as structure-based drug design, ligand- and fragment-based approaches, and prodrug development. The role of diverse chemical classes, including nucleoside analogues, non-nucleoside inhibitors, and peptidomimetics, is critically analyzed alongside structure–activity relationship principles that guide optimization. Additionally, the review highlights challenges related to drug resistance and emphasizes strategies to overcome them, as well as the importance of ADMET considerations in drug development. Emerging trends, including artificial intelligence-driven design, covalent inhibitors, and advanced drug delivery systems, are also explored. Overall, this review outlines current advancements and future directions in antiviral medicinal chemistry for the development of next-generation therapeutics
Zitieren
APA
Padmavathi, V., Jadhav, S., Tejasvi, S., Kumar, T. K., & Dixit, P. R. (2026). Medicinal Chemistry Perspectives in the Design of Novel Antiviral Agents. International Journal of Drug Delivery Technology, 16(46s). https://doi.org/10.25258/ijddt.16.46s.16
Vancouver
Padmavathi V, Jadhav S, Tejasvi S, Kumar TK, Dixit PR. Medicinal Chemistry Perspectives in the Design of Novel Antiviral Agents. International Journal of Drug Delivery Technology. 2026;16(46s). doi:10.25258/ijddt.16.46s.16
BibTeX
@article{Padmavathi2026,
author = {Padmavathi, Vustelamuri and Jadhav, Smita and Tejasvi, Sarika and Kumar, T Kranthi and Dixit, Pravat Ranjan},
title = {Medicinal Chemistry Perspectives in the Design of Novel Antiviral Agents},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {46s},
doi = {10.25258/ijddt.16.46s.16}
}
EUVIMED